Aldeyra Therapeutics
Neutralizing Aldehyde Toxicity | Treatment Of Noninfectious Anterior Uveitis And Sjögren-Larsson Syndrome | Aldeyra Therapeutics | Aldeyra Therapeutics. Learn more
Launch date
Employees
Market cap
€335m
Enterprise valuation
€240m (Public information from Sep 2024)
Share price
$5.87 ALDX
Lexington Massachusetts (HQ)
Authorizing premium user...